NCT05024968 2026-02-25
Sintilimab in Cancer of Unknown Primary
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
4 trialsNCT04398927 2021-02-04
Systemic Chemotherapy Plus PD-1 for Metastasis ICC
Sun Yat-sen University
Phase 2 Withdrawn
NCT04400851 2020-09-03
Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Sun Yat-sen University
Phase 1 Unknown
NCT04202601 2019-12-19
Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer
Peking University
Phase 1/2 Unknown